Endo Health Solutions

NASDAQ: ENDP

ENDP Articles

These are five stocks for very aggressive accounts looking to get share-count leverage on companies that have sizable upside potential.
The top analyst upgrades, downgrades and initiations seen on Monday included Alarm.com, Exxon Mobil, Goldman Sachs BDC, Merck, Pinterest, Shopify, Wendy's and Zoom Video Communications.
The top analyst upgrades, downgrades and initiations seen on Wednesday included Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra Energy, Peabody Energy, Teva Pharmaceutical and...
24/7 Wall St. tracked 10 companies seeing three or more analyst rating upgrades or price target hikes on Thursday, August 9, 2018.
The top analyst upgrades, downgrades and other research calls from Thursday include Alphabet, Avon, Bank of America, Intel, Roku, Snap and Western Digital.
Endo International saw its shares make a solid gain to start off the week after the firm announced preliminary financial results for its third quarter.
October 17, 2017: Here are four stocks trading with heavy volume among 72 equities making new 52-week lows in Tuesday’s session. On the NYSE, decliners led advancers by about 8 to 7 and on the...
The top analyst upgrades, downgrades and other research calls include Archer Daniels Midland, BlackRock, DexCom, Mallinckrodt, McDonald's, Philip Morris and Redfin.
Teva, Endo, Plains All American, and Whiting Petroleum all posted new 52-week lows Tuesday.
In an unprecendented move, the U.S. Food and Drug administration (FDA) requested that Endo International remove its Opana ER from the market. Ultimately, the agency held concerns about abuse...
In an unprecedented move, the FDA has requested that Endo International remove its opioid pain medication from the market. The agency now believes that the benefits of the drug may no longer outweigh...
The top analyst upgrades, downgrades and other research calls from Friday include AMD, Camping World, Endo International, Nordstrom, NVIDIA, Snap, Starbucks and Zynga.
Frontier Communications, Rubicon Project, Endo Pharmaceuticals, and NeoPhotonics all posted new 52-week lows Wednesday.
DryShips, Teva, Endo Pharma, and Gilead Sciences posted new 52-week lows Monday.
No matter the underlying causes, the fluctuation of a given company’s stock price is indicative of investor confidence.